NMN

NMN (β-nicotinamide mononucleotide) is a small molecule sold as an anti-aging and metabolic “NAD+ booster.” Here’s the honest summary: the one thing that reliably holds up in humans is that NMN raises the level of NAD+ byproducts in your blood. Everything beyond that is shaky. The human studies are small, short, and mostly measure stand-in markers rather than real-world health outcomes — and no human trial has ever shown that NMN extends life or delivers a clear anti-aging result.

What it is

NMN is a nucleotide — a building-block molecule. Specifically, it’s nicotinamide (a form of vitamin B3) attached to a ribose-phosphate (a sugar-and-phosphate group). Your body uses it as a direct step on the way to making NAD+ (nicotinamide adenine dinucleotide, a molecule cells need to run their energy machinery).

The body builds NAD+ through a recycling route called the salvage pathway. In it, nicotinamide gets turned into NMN by an enzyme called NAMPT (the bottleneck, or slowest, step). NMN is then turned into NAD+ by a group of enzymes called NMNAT1/2/3.

NAD+ matters because it’s a coenzyme (a helper molecule) at the center of how cells turn food into energy — including glycolysis, the TCA cycle, and oxidative phosphorylation (the main energy-producing steps inside cells). It’s also used up by several other enzymes, including the sirtuins (SIRT1–7), PARPs, and CD38. NAD+ levels drop with age in many tissues, and that decline is the main reason people give for wanting to “boost” it.

How NMN actually gets inside cells is still an open question. One study reported a transporter called Slc12a8 that carries NMN straight into cells (Grozio et al., 2019), but that claim is disputed — another published paper pushed back on it, and the original study now carries an Author Correction. A lot of NMN also gets broken down outside the cell into a related molecule, nicotinamide riboside (NR), and absorbed that way instead. Scientists haven’t settled how much of each route does the work.

NMN is NOT a peptide. It is also not a SARM and not an anabolic steroid.

The claims

Sellers and users say NMN does a long list of things: slows aging and promotes “longevity,” raises NAD+, gives you more energy, improves how your mitochondria (the cell’s power plants) work, boosts exercise capacity and recovery, improves insulin sensitivity, helps the heart and the brain, and even supports “DNA repair.” Most of this sales pitch leans on mouse studies and the broader sirtuin/longevity story rather than on actual human results.

What the evidence actually shows

The human trials are small, short, and mostly measure surrogate endpoints (lab markers that stand in for real health outcomes, rather than the outcomes themselves). No human trial has shown a longer lifespan or a clear, lasting anti-aging benefit. The one finding that keeps showing up reliably is simply that NMN raises NAD+ byproducts in the blood.

• Yoshino et al., Science 2021: A randomized, placebo-controlled trial (the gold-standard study design) in postmenopausal women who were overweight and prediabetic. It found better insulin sensitivity in skeletal muscle (measured by a clamp, a careful lab test of how the body handles blood sugar) but no change in body weight, blood pressure, cholesterol, or other metabolic markers. It was done at a single site with a modest number of participants.
• Irie et al., Endocrine Journal 2020: A small safety study in healthy Japanese men with no comparison group. A single dose by mouth was tolerated, with shifts in some metabolites. It wasn’t set up to test whether NMN actually works.
• Liao et al., JISSN 2021: A 6-week, randomized, double-blind, placebo-controlled trial (neither participants nor researchers knew who got what) with four groups and 48 recreational runners. It reported that aerobic fitness improved more at higher doses. Still small, and still based on stand-in markers.
• Several other small randomized trials report rises in NAD+ and some functional improvements, but the results are mixed or only weakly significant.

The animal research is broader, but it hasn’t been proven to carry over to people:

• Mills et al., Cell Metabolism 2016: Mice given NMN for 12 months had fewer of the usual age-related declines (in body weight, energy use, insulin sensitivity, and eye function) and tolerated it well. This study is a centerpiece of the marketing story.
• de Picciotto et al., Aging Cell 2016: In aged mice, NMN lowered oxidative stress in blood vessels and improved how arteries worked.
• A large body of rodent research shows benefits from restoring NMN/NAD+ in metabolic, vascular, and brain-disease stress models — but none of this has been shown to work the same way in humans.

The bottom line on evidence: the only well-supported claim is that NMN “raises NAD+.” Evidence for real clinical benefit in people is preliminary and based on stand-in markers, and there’s no human data backing the life-extension claims.

Legal and regulatory status

Whether NMN can legally be sold as a dietary supplement in the US is genuinely up in the air. In late 2022 the FDA took the position that NMN is excluded from the legal definition of a dietary supplement because it had been “authorized for investigation as a new drug,” with serious clinical studies started and made public. That’s the same statutory exclusion (FD&C Act 201(ff)(3)(B)) the agency had earlier applied to NR. This reversed the FDA’s own earlier acknowledgment of new-dietary-ingredient notifications for NMN-containing products.

In practice, the FDA has signaled that NMN may not be lawfully sold as a dietary supplement — but as of mid-2026 it’s still widely sold in the US, and the agency hasn’t carried out broad enforcement to pull it off the market. Amazon delisted NMN supplements in 2022, citing the FDA’s position. So treat the question “is NMN a legal supplement?” as unresolved, not settled.

NMN is NOT a controlled substance — the DEA hasn’t scheduled it. It is NOT an anabolic steroid, so the Anabolic Steroid Control Act doesn’t apply to it.

On the doping side: NMN is NOT on the WADA Prohibited List, and it isn’t a SARM or a hormone/metabolic modulator. NAD+ precursors are not currently banned by WADA. (That said, athletes still face strict-liability contamination risk — meaning they’re held responsible for whatever’s actually in any unregulated supplement they take, even if it’s not on the label.)

Safety

In the short term, NMN has generally looked acceptable in people. Across the small, short trials done so far, it’s been well tolerated, with no consistent sign of serious side effects at the amounts studied, and only mild reported issues (for example, temporary stomach or digestive complaints in some people).

The honest gaps and concerns:

• Long-term safety is basically unknown — there are no large or long-running human safety studies.
• A theoretical cancer concern: dividing cells use NAD+ to grow, so raising NAD+ in someone who has a hidden (undetected) cancer is biologically plausible as a risk — but this is UNPROVEN. No human trial shows NMN causes or speeds up cancer; this is flagged as a theoretical worry only.
• Product-quality risk: NMN is an unregulated supplement, and third-party testing of NAD-precursor products in general has turned up cases where the label doesn’t match what’s actually in the bottle, along with purity problems.

One clarification: liver toxicity, suppressed testosterone, lowered HDL/cholesterol, vision loss, QT prolongation (a heart-rhythm effect), and cancer-causing potential are warning signs tied to SARMs, anabolic steroids, and compounds like GW-501516 — not to NMN. They have no established link to NMN and are not pinned on it here.

Bottom line

NMN reliably raises NAD+ in humans — that part is real and has been repeated. But raising NAD+ is not the same as proving the anti-aging, metabolic, or performance benefits it’s sold for. The human evidence is small, short, and based on stand-in markers; the strongest supporting data are in mice. Its legal status as a US supplement is genuinely unsettled, and its long-term safety simply hasn’t been studied. It is not a peptide, not a controlled substance, and not WADA-banned.

Evidence grade: 6/10 · Preliminary.

Sources

• Yoshino M, et al. Science. 2021;372(6547):1224-1229. PMID 33888596
• Irie J, et al. Endocr J. 2020;67(2):153-160. PMID 31685720
• Liao B, et al. J Int Soc Sports Nutr. 2021;18(1):54. PMID 34238308
• Mills KF, et al. Cell Metab. 2016;24(6):795-806. PMID 28068222
• de Picciotto NE, et al. Aging Cell. 2016;15(3):522-530. PMID 26970090
• Grozio A, et al. Nat Metab. 2019;1(1):47-57. PMID 31131364 (transporter claim contested — rebuttal PMID 32694650; Author Correction PMID 32694647)